233 related articles for article (PubMed ID: 19845042)
21. Regulation of innate immune response to Candida albicans infections by αMβ2-Pra1p interaction.
Soloviev DA; Jawhara S; Fonzi WA
Infect Immun; 2011 Apr; 79(4):1546-58. PubMed ID: 21245270
[TBL] [Abstract][Full Text] [Related]
22. Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA.
Dimitrova P; Yordanov M; Danova S; Ivanovska N
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):231-6. PubMed ID: 18507679
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection.
Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F
J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189
[TBL] [Abstract][Full Text] [Related]
24. Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen.
Tansho S; Ab S; Mizutani S; Ono Y; Takesako K; Yamaguchi H
Microbiol Immunol; 2002; 46(5):307-11. PubMed ID: 12139389
[TBL] [Abstract][Full Text] [Related]
25. Protection from systemic Candida albicans infection by inactivation of the Sts phosphatases.
Naseem S; Frank D; Konopka JB; Carpino N
Infect Immun; 2015 Feb; 83(2):637-45. PubMed ID: 25422266
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of intrinsic and acquired immune cells infiltration in kidney and spleen of the mice infected with systemic candidiasis and treated with chloroform fraction of Zataria Multiflora Boiss.
Bayat M; Hassannejad N; Ghazanfari H
Microb Pathog; 2018 Jan; 114():444-448. PubMed ID: 29183758
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of kidney and spleen cytokine responses in mice challenged with pathology-standardized doses of Candida albicans mannosylation mutants.
Castillo L; MacCallum DM; Brown AJ; Gow NA; Odds FC
Infect Immun; 2011 Jan; 79(1):146-52. PubMed ID: 21059878
[TBL] [Abstract][Full Text] [Related]
28. Host response to Candida albicans bloodstream infection and sepsis.
Duggan S; Leonhardt I; Hünniger K; Kurzai O
Virulence; 2015; 6(4):316-26. PubMed ID: 25785541
[TBL] [Abstract][Full Text] [Related]
29. Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain.
Mullick A; Elias M; Picard S; Bourget L; Jovcevski O; Gauthier S; Tuite A; Harakidas P; Bihun C; Massie B; Gros P
Infect Immun; 2004 Oct; 72(10):5868-76. PubMed ID: 15385488
[TBL] [Abstract][Full Text] [Related]
30. IL-13 attenuates early local CXCL2-dependent neutrophil recruitment for Candida albicans clearance during a severe murine systemic infection.
Abe Y; Yamamoto N; Nakamura K; Arai K; Sakurai C; Hatsuzawa K; Ogura Y; Iseki K; Tase C; Kanemitsu K
Immunobiology; 2019 Jan; 224(1):15-29. PubMed ID: 30514570
[TBL] [Abstract][Full Text] [Related]
31. Trained Innate Immunity Induced by Vaccination with Low-Virulence
Lilly EA; Bender BE; Esher Righi S; Fidel PL; Noverr MC
mBio; 2021 Oct; 12(5):e0254821. PubMed ID: 34663098
[TBL] [Abstract][Full Text] [Related]
32. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
[TBL] [Abstract][Full Text] [Related]
33. Endogenous thrombospondin-1 regulates leukocyte recruitment and activation and accelerates death from systemic candidiasis.
Martin-Manso G; Navarathna DH; Galli S; Soto-Pantoja DR; Kuznetsova SA; Tsokos M; Roberts DD
PLoS One; 2012; 7(11):e48775. PubMed ID: 23144964
[TBL] [Abstract][Full Text] [Related]
34. Systemic Candidiasis and TLR2 Agonist Exposure Impact the Antifungal Response of Hematopoietic Stem and Progenitor Cells.
Martínez A; Bono C; Megías J; Yáñez A; Gozalbo D; Gil ML
Front Cell Infect Microbiol; 2018; 8():309. PubMed ID: 30234030
[TBL] [Abstract][Full Text] [Related]
35. Role of interleukin-18 in host defense against disseminated Candida albicans infection.
Stuyt RJ; Netea MG; Verschueren I; Fantuzzi G; Dinarello CA; Van Der Meer JW; Kullberg BJ
Infect Immun; 2002 Jun; 70(6):3284-6. PubMed ID: 12011026
[TBL] [Abstract][Full Text] [Related]
36. The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections.
Bishu S; Hernández-Santos N; Simpson-Abelson MR; Huppler AR; Conti HR; Ghilardi N; Mamo AJ; Gaffen SL
Infect Immun; 2014 Mar; 82(3):1173-80. PubMed ID: 24379290
[TBL] [Abstract][Full Text] [Related]
37. Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections.
MacCallum DM; Castillo L; Brown AJ; Gow NA; Odds FC
PLoS One; 2009 Jul; 4(7):e6420. PubMed ID: 19641609
[TBL] [Abstract][Full Text] [Related]
38. Induction of tumor necrosis factor-alpha in murine Candida albicans infection.
Allendoerfer R; Magee DM; Smith JG; Bonewald L; Graybill JR
J Infect Dis; 1993 May; 167(5):1168-72. PubMed ID: 8486950
[TBL] [Abstract][Full Text] [Related]
39. Murine candidiasis: cell-mediated immune responses correlate directly with susceptibility and resistance to infection.
Ashman RB
Immunol Cell Biol; 1990 Feb; 68 ( Pt 1)():15-20. PubMed ID: 2180815
[TBL] [Abstract][Full Text] [Related]
40. Looking into Candida albicans infection, host response, and antifungal strategies.
Wang Y
Virulence; 2015; 6(4):307-8. PubMed ID: 25590793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
